MTCM
BSX icon

Mint Tower Capital Management’s Boston Scientific BSX Stock Holding History

Mint Tower Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,200
Closed -$1.07M – 344
2021
Q4 		$1.07M Sell
25,200
-14,800
-37% -$622K 0.14% 133
2021
Q3 		$1.74M Hold
40,000
– – 0.22% 93
2021
Q2 		$1.71M Buy
+40,000
New +$1.68M 0.12% 139

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Mint Tower Capital Management's BSX Position: Q3 2021 in Review

Mint Tower Capital Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 3,262 shares — an estimated $144K sold.

Mint Tower Capital Management first reported a position in BSX in Q2 2021 and held it in 1 quarter. The position peaked at $139K in Q2 2021. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Mint Tower Capital Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 3,262 Boston Scientific shares in Q3 2021, an estimated $144K.
  • Mint Tower Capital Management first reported a position in Boston Scientific in Q2 2021 and held it in 1 quarter.
  • Mint Tower Capital Management's Boston Scientific position peaked at $139K in Q2 2021.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Mint Tower Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.